FIELD: medicine. SUBSTANCE: method deals with gradual subcutaneous injection of M-cholinolytic preparation once daily and an anticholinesterase preparation for 8-10 d, moreover, the latter should be injected at the background of M- cholinolytic action. The method enables to shorten therapy terms and avoid undesirable side effects. EFFECT: higher efficiency of therapy. 3 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING LARYNX MOVEMENT DISORDERS | 2002 |
|
RU2236223C2 |
| METHOD OF TREATMENT OF NEURITIS OF THE FACIAL NERVE | 0 |
|
SU1416127A1 |
| METHOD OF TREATMENT OF PATIENTS WITH BRONCHOOBSTRUCTIVE SYNDROME | 1996 |
|
RU2136273C1 |
| METHOD OF REVEALING NEUROSENSOR HEARING DISORDER AND ITS GROUP OF RISK | 1995 |
|
RU2084898C1 |
| METHOD OF TREATMENT OF PATIENTS WITH CENTRAL NEUROLOGICAL DISORDERS AT CEREBRAL CIRCULATION IMPAIRMENT AND CENTRAL NERVOUS SYSTEM TRAUMAS | 1996 |
|
RU2126689C1 |
| METHOD FOR SURGICAL MANAGEMENT OF MIDDLE EAR MASSES | 2021 |
|
RU2769917C1 |
| METHOD FOR TREATING HYPERREFLECTOR-TYPE DISURIA | 0 |
|
SU1734753A1 |
| METHOD OF TREATMENT OF INJURIES OF PERIPHERIC NERVES | 0 |
|
SU1147400A1 |
| METHOD OF TREATMENT OF NEUROSENSORY IMPAIRED HEARING | 1996 |
|
RU2108793C1 |
| METHOD OF TREATING NEUROSENSOR HEARING DISORDER | 1993 |
|
RU2094067C1 |
